Global Biomarker Technologies Market By Product Type (Consumables, Instruments), By Technology (Immunoassay, PCR, Imaging Technologies, Chromatography), By Application (Drug Discovery, Diagnostics, Personalized Medicine) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Biomarker Technologies Market Introduction

Neurodiagnostics is the field of healthcare that deals with monitoring, recording, and analyzing the nervous system for diagnosing pathologic conditions. A healthcare professional or a technologist records the electrical signals from the brain, peripheral nerves, spinal cord, and motor nerve system using various instruments and techniques. These professionals prepare a document that is further used by a doctor in the diagnosis and treatment of disorders. Common types of neurological tests are Electroencephalogram (EEG), Polysomnogram (PSG), Intraoperative Neuromonitoring (IONM), Long-Term Monitoring (LTM), etc.

A professional performing a neurodiagnostic procedure must meet a specific minimum education qualification and performance standards, perform with a code of ethics, and perform a procedure under the direction of a physician. Some disorders that can be tracked with neurodiagnostic systems include autonomic disorders, epilepsy, head trauma, brain tumors, Parkinson’s disease, neuromuscular diseases, multiple sclerosis, etc.

The global biomarker technologies market is segmented based on – product type, technology, indication, application, end-user, and region.

Detailed segmentation is as below:

By Product Type

• Consumables
• Instruments

By Technology

• Immunoassay
  • ELISA
  • Western Blot
  • Protein Microarray
• PCR
• Imaging Technologies
• Mass Spectrometry
• NGS
• Chromatography
• Cytogenetics
• Other Profiling Technologies

By Indication

• Cancer
• Infectious Diseases
• Autoimmune Disorders
• Neurological Disorders
• Cardiovascular Disorders
• Other Indications

By Application

• Drug Discovery
• Diagnostics
• Personalized Medicine

By End-User

• Hospitals
• Specialty Clinics
• Diagnostic Laboratories
• Ambulatory Surgical Centers
• Research Laboratories & Institutes

By Region

• North America
  The US
  Canada
  Mexico
• Europe
  Germany
  UK
  France
  Italy
  Spain
  Russia
  Rest of Europe
• Asia-Pacific
  China
  Japan
  India
  Korea
  Rest of Asia-Pacific
• South America
  Brazil
  Argentina
  Rest of South America
• The Middle East and Africa
  GCC
  Israel
  South Africa
  Rest of MEA

Market Dynamics

Increasing incidences of neurological disorders, technological advancements in diagnostic devices, and awareness concerning the early diagnosis of diseases are key factors augmenting the market for neurodiagnostic. The increasing incidences of epilepsy are also contributing to this target market’s growth; for instance, according to the WHO (World Health Organization), more than 50 million individuals are affected by this disorder, and according to the CDC (Centers for Disease Control and Prevention), in 2015, 3.4 million people in the US suffered from epilepsy. Product recalls associated with medical diagnostic devices, the unavailability of skilled medical professionals, and the low awareness rate about the diseases in low-income nations hamper market growth opportunities for the neurodiagnostic industry to a certain extent. Furthermore, the increase in R&D activities, as well as increased support by respective governments and private sectors towards the expansion of the healthcare industry in developed as well as developing nations, are factors that are expected to create lucrative opportunities for key players through the increasing of their product offerings and respective geographical presence.

Competitive Landscape

Major players in this market are

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Hitachi Ltd.
• Canon Inc.
• Lifelines Neuro Company LLC
• Natus Medical Incorporated
• Hoffman-La Roche AG
• FUJIFILM Holdings Corporation
• Mitsar Co. Ltd.
• Advanced Brain Monitoring
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories
• QIAGEN N.V.
• Nihon Kohden Corporation
• ANT Neuro
• Fonar Corporation
• Fujirebio
• DRG Instruments GmbH
• Tecan Trading AG
• Motion Lab Systems Inc.
• Rigaku Corporation
• Neusoft Medical Systems Co. Ltd.
• ELMIKO MEDICAL Sp. Z o.o.
• Ridge Diagnostics

Key Developments:

In June 2020, Heart2Save and Lumoava developed an ECG necklace, AiVOni Lumoava, that helps self-monitor by delivering arrhythmia analysis.

In September 2020, AliveCOR entered the Indian market by launching a new personal ECG device.
In February 2019, Philips Healthcare launched the Incisive CT Platform and Ingenia Ambition 1.5T MRI System.

For the Biomarker Technologies Market research study, the following years have been considered to estimate the market size: